First Time Loading...

Standard BioTools Inc
NASDAQ:LAB

Watchlist Manager
Standard BioTools Inc Logo
Standard BioTools Inc
NASDAQ:LAB
Watchlist
Price: 2.51 USD -0.79% Market Closed
Updated: May 6, 2024

Standard BioTools Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard BioTools Inc
Cash from Financing Activities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Standard BioTools Inc
NASDAQ:LAB
Cash from Financing Activities
-$6.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Financing Activities
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash from Financing Activities
-$144m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
17%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Financing Activities
-$859.6m
CAGR 3-Years
-5%
CAGR 5-Years
-17%
CAGR 10-Years
-13%
Agilent Technologies Inc
NYSE:A
Cash from Financing Activities
-$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
IQVIA Holdings Inc
NYSE:IQV
Cash from Financing Activities
-$382m
CAGR 3-Years
-21%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Standard BioTools Inc's Cash from Financing Activities?
Cash from Financing Activities
-6.8m USD

Based on the financial report for Dec 31, 2023, Standard BioTools Inc's Cash from Financing Activities amounts to -6.8m USD.